• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响初发心脏移植受者长期预后的心血管危险因素的多中心回顾性分析。

Multicenter retrospective analysis of cardiovascular risk factors affecting long-term outcome of de novo cardiac transplant recipients.

作者信息

Kobashigawa Jon A, Starling Randall C, Mehra Mandeep R, Kormos Robert L, Bhat Geetha, Barr Mark L, Sigouin Chris S, Kolesar June, Fitzsimmons William

机构信息

University of California at Los Angeles, Los Angeles, California 90095, USA.

出版信息

J Heart Lung Transplant. 2006 Sep;25(9):1063-9. doi: 10.1016/j.healun.2006.05.001. Epub 2006 Jul 18.

DOI:10.1016/j.healun.2006.05.001
PMID:16962467
Abstract

BACKGROUND

Previous risk factor studies in cardiac transplant patients have analyzed pre-transplant risk factors as they relate to outcomes. This study is the first in-depth multicenter assessment of ongoing post-transplant risk factors in heart transplant patients and their impact on 5-year outcomes.

METHODS

We reviewed 280 heart transplant patients who survived > 1 year for the impact of post-transplant risk factors (hyperlipidemia, hypertension, diabetes, body mass index [BMI] and renal dysfunction: 8 to 18 possible measurements over 5 years) on outcomes, including death, cardiac allograft vasculopathy (CAV) and non-fatal major adverse cardiac events (NF-MACE).

RESULTS

Upon multivariate Cox regression analysis, significant findings were high total-cholesterol for NF-MACE (relative risk [RR] = 4.34, confidence interval [CI] 1.35 to 13.98, p = 0.01), presence of diabetes for NF-MACE (RR = 3.96, CI 1.24 to 12.65, p = 0.02) and high serum creatinine for graft death (RR = 1.59, CI 1.35 to 1.87, p < 0.001). No covariates were found to be significant for CAV. Other significant risk factors by univariate Cox regression models with time-dependent covariates included BMI > or = 33 for graft death.

CONCLUSIONS

Post-transplant risk factors of hypercholesterolemia and diabetes are associated with NF-MACE, whereas high serum creatinine and BMI > or = 33 are associated with graft death. Risk factor modification, including direct therapy to minimize risk factors, should be considered.

摘要

背景

先前针对心脏移植患者的危险因素研究分析了移植前危险因素与预后的关系。本研究是首次对心脏移植患者移植后持续存在的危险因素及其对5年预后的影响进行深入的多中心评估。

方法

我们回顾了280例存活超过1年的心脏移植患者,以评估移植后危险因素(高脂血症、高血压、糖尿病、体重指数[BMI]和肾功能不全:5年内8至18项可能的测量指标)对包括死亡、心脏移植血管病变(CAV)和非致命性主要不良心脏事件(NF-MACE)在内的预后的影响。

结果

经多变量Cox回归分析,显著发现包括:总胆固醇水平高与NF-MACE相关(相对风险[RR]=4.34,置信区间[CI]1.35至13.98,p=0.01),糖尿病与NF-MACE相关(RR=3.96,CI 1.24至12.65,p=0.02),血清肌酐水平高与移植物死亡相关(RR=1.59,CI 1.35至1.87,p<0.001)。未发现有协变量对CAV有显著影响。单变量Cox回归模型结合时间依赖性协变量分析发现的其他显著危险因素包括BMI≥33与移植物死亡相关。

结论

移植后高胆固醇血症和糖尿病等危险因素与NF-MACE相关,而血清肌酐水平高和BMI≥33与移植物死亡相关。应考虑对危险因素进行调整,包括采取直接治疗措施以尽量降低危险因素。

相似文献

1
Multicenter retrospective analysis of cardiovascular risk factors affecting long-term outcome of de novo cardiac transplant recipients.影响初发心脏移植受者长期预后的心血管危险因素的多中心回顾性分析。
J Heart Lung Transplant. 2006 Sep;25(9):1063-9. doi: 10.1016/j.healun.2006.05.001. Epub 2006 Jul 18.
2
Effect of body mass index on outcome in pediatric heart transplant patients.体重指数对小儿心脏移植患者预后的影响。
J Heart Lung Transplant. 2007 Jul;26(7):718-23. doi: 10.1016/j.healun.2007.05.001.
3
Renal transplant dysfunction--importance quantified in comparison with traditional risk factors for cardiovascular disease and mortality.肾移植功能障碍——与心血管疾病和死亡的传统风险因素相比,其重要性得到量化。
Nephrol Dial Transplant. 2006 Aug;21(8):2282-9. doi: 10.1093/ndt/gfl095. Epub 2006 Mar 30.
4
Effects of body mass index at transplant on outcomes of kidney transplantation.移植时体重指数对肾移植结局的影响。
Transplantation. 2007 Oct 27;84(8):981-7. doi: 10.1097/01.tp.0000285290.77406.7b.
5
Influence of traditional cardiovascular risk factors in the recipient on the development of cardiac allograft vasculopathy after heart transplantation.心脏移植后,受者传统心血管危险因素对心脏移植血管病变发生发展的影响。
Transplant Proc. 2008 Nov;40(9):3056-7. doi: 10.1016/j.transproceed.2008.08.115.
6
Ischemic heart disease after renal transplantation in patients on cyclosporine in Spain.西班牙接受环孢素治疗的肾移植患者的缺血性心脏病
J Am Soc Nephrol. 2006 Dec;17(12 Suppl 3):S286-90. doi: 10.1681/ASN.2006080928.
7
Risk factors of long-term graft loss in renal transplant recipients with chronic allograft dysfunction.慢性移植肾功能不全的肾移植受者长期移植肾失功的危险因素。
Exp Clin Transplant. 2010 Dec;8(4):277-82.
8
Prehypertension, obesity, and risk of kidney disease: 20-year follow-up of the HUNT I study in Norway.高血压前期、肥胖与肾病风险:挪威HUNT I研究的20年随访
Am J Kidney Dis. 2009 Oct;54(4):638-46. doi: 10.1053/j.ajkd.2009.03.023. Epub 2009 Jun 10.
9
Obesity in renal transplantation: analysis of 2691 patients.肾移植中的肥胖:对2691例患者的分析。
Transplant Proc. 2005 Nov;37(9):3695-7. doi: 10.1016/j.transproceed.2005.10.069.
10
New-onset cardiovascular risk factors in lung transplant recipients.肺移植受者新发心血管危险因素
J Heart Lung Transplant. 2005 Oct;24(10):1536-43. doi: 10.1016/j.healun.2005.01.004.

引用本文的文献

1
Long-term changes in body weight and serum cholesterol in heart transplant recipients.心脏移植受者体重和血清胆固醇的长期变化。
Clin Transplant. 2022 Dec;36(12):e14819. doi: 10.1111/ctr.14819. Epub 2022 Sep 25.
2
Dyslipidemia in Transplant Patients: Which Therapy?移植患者的血脂异常:哪种治疗方法?
J Clin Med. 2022 Jul 14;11(14):4080. doi: 10.3390/jcm11144080.
3
Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Use for Atherogenic Dyslipidemia in Solid Organ Transplant Patients.前蛋白转化酶枯草杆菌蛋白酶/克新9型抑制剂在实体器官移植患者致动脉粥样硬化性血脂异常中的应用
J Clin Med. 2022 Jun 6;11(11):3247. doi: 10.3390/jcm11113247.
4
Low-Density Lipoprotein Cholesterol Level Trends and the Development of Cardiac Allograft Vasculopathy After Heart Transplantation.心脏移植后低密度脂蛋白胆固醇水平变化趋势与心脏移植血管病变的发生
CJC Open. 2021 Jul 16;3(12):1453-1462. doi: 10.1016/j.cjco.2021.07.011. eCollection 2021 Dec.
5
Clinical phenomapping and outcomes after heart transplantation.心脏移植后的临床表型映射和结局。
J Heart Lung Transplant. 2018 Aug;37(8):956-966. doi: 10.1016/j.healun.2018.03.006. Epub 2018 Mar 22.
6
Management Strategies for Posttransplant Diabetes Mellitus after Heart Transplantation: A Review.心脏移植术后移植后糖尿病的管理策略:综述
J Transplant. 2018 Jan 29;2018:1025893. doi: 10.1155/2018/1025893. eCollection 2018.
7
No Obesity Paradox in Pediatric Patients With Dilated Cardiomyopathy.扩张型心肌病患儿中不存在肥胖悖论。
JACC Heart Fail. 2018 Mar;6(3):222-230. doi: 10.1016/j.jchf.2017.11.015. Epub 2018 Feb 7.
8
Clinical outcomes in overweight heart transplant recipients.超重心脏移植受者的临床结局
Heart Lung. 2016 Jul-Aug;45(4):298-304. doi: 10.1016/j.hrtlng.2016.03.005. Epub 2016 Apr 14.
9
Post-transplant dyslipidemia: Mechanisms, diagnosis and management.移植后血脂异常:机制、诊断与管理
World J Transplant. 2016 Mar 24;6(1):125-34. doi: 10.5500/wjt.v6.i1.125.
10
The varying effects of obesity and morbid obesity on outcomes following cardiac transplantation.肥胖和病态肥胖对心脏移植术后结局的不同影响。
Int J Obes (Lond). 2016 Apr;40(4):721-4. doi: 10.1038/ijo.2016.20. Epub 2016 Feb 8.